N/A
Completed N=10
Diabetes Homeless Medication Support Single Arm Treatment Development Trial
Type 2 Diabetes · Homeless Persons
Source: ClinicalTrials.gov NCT04678284 ↗
Enrolled (actual)
10
Serious AEs
0.0%
Results posted
Apr 2023
Primary outcomePrimary: Acceptability of Intervention — 25.4 score on a scale
Summary
This single-arm trial of the Diabetes Homeless Medication Support intervention alone (n=15) will test the perception and feasibility of anticipated study procedures.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Acceptability of Intervention |
25.4 | — |
| SECONDARY Hemoglobin A1c |
-0.5 | — |
| SECONDARY Psychological Wellness |
-2.6 | — |
| SECONDARY Diabetes Medication Adherence |
0.6 | — |
Eligibility Criteria
Inclusion Criteria
- Age 18 yrs. or older
- English-speaking
- Homelessness by federal definition in the last 12 mo.
- Self-reported diagnosis of type 2 diabetes, later verified in medical record
- Plan to stay in local area or be reachable by phone for the next 16 weeks
- Willingness to work on medication adherence and diabetes self-care
- HbA1c >/= 7.5%
Exclusion Criteria
- Inability to provide informed consent (e.g., presence of a legal guardian, prisoners)
- Active psychosis or intoxication precluding ability to give informed consent
- Pregnant or lactating females.
- Patients who choose to opt out of research.
Data sourced from ClinicalTrials.gov (NCT04678284). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.